OWC Pharmaceutical Research Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 12/19/2016
Contact Info
  • 30 Shacham Street
  • P.O.B. 8324
  • Petach-Tikva 4918103
  • Israel

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001431934
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2008
Employees 6 a/o Feb 25, 2016
Company Officers/Contacts
Mordechai Bignitz CEO, President
Ziv Turner COO
Shmuel De-Saban CFO
Yehuda Baruch Chief Scientific Officer, Director, R&D
Richard Rubin Counsel
Company Directors
Mordechai Bignitz Chairman
Service Providers
Accounting/Auditing Firm
4100 North Sam Houston Pkwy W
Suite 200-B
Houston, TX, 77086
United States
Securities Counsel
Office of Richard Rubin
40 Wall Street 28th Floor
New York, NY, 10005
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Dynamic Applications Corp. until 1-2015
OWCP Security Details
Share Structure
Market Value1 $185,774,227 a/o Mar 27, 2017
Authorized Shares 500,000,000 a/o Mar 01, 2017
Outstanding Shares 144,011,029 a/o Mar 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 86,515,750 a/o Oct 31, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 250 a/o Oct 31, 2016
Short Selling Data
Short Interest 1,594,748 (-9.89%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security